KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Change in Accured Expenses (2016 - 2026)

Biogen has reported Change in Accured Expenses over the past 18 years, most recently at -$243.2 million for Q1 2026.

  • For Q1 2026, Change in Accured Expenses rose 19.07% year-over-year to -$243.2 million; the TTM value through Mar 2026 reached -$190.7 million, up 36.88%, while the annual FY2025 figure was -$248.0 million, 38.78% down from the prior year.
  • Change in Accured Expenses for Q1 2026 was -$243.2 million at Biogen, down from -$215.3 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $1.1 billion in Q2 2022 and troughed at -$745.7 million in Q4 2022.
  • A 5-year average of -$57.9 million and a median of -$94.5 million in 2024 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 854.76% in 2022 and later skyrocketed 24864.71% in 2023.
  • Year by year, Change in Accured Expenses stood at -$745.7 million in 2022, then soared by 33.55% to -$495.5 million in 2023, then skyrocketed by 80.93% to -$94.5 million in 2024, then tumbled by 127.83% to -$215.3 million in 2025, then dropped by 12.96% to -$243.2 million in 2026.
  • Business Quant data shows Change in Accured Expenses for BIIB at -$243.2 million in Q1 2026, -$215.3 million in Q4 2025, and $286.0 million in Q3 2025.